BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This formulation features distearoylphosphatidylethanolamine-polyethylene glycol modified emodin liposomes (DSPE-Emo LPs) utilizing a sterically stabilized framework. The structural matrix incorporates the hydrophobic anthraquinone derivative emodin directly into the hydrocarbon core of a phospholipid bilayer, while the outer surface is integrated with distearoylphosphatidylethanolamine-polyethylene glycol (DSPE-PEG) polymer-lipid conjugates. The integration of these specialized polymer-lipid conjugates modifies membrane curvature and introduces a dense hydrophilic steric shield on the outer boundary. This configuration prevents physical vesicle aggregation and controls the passive crystallization of the anthraquinone cargo in open aqueous suspension.
Source
Custom synthesis
Functional Group
Distearoylphosphatidylethanolamine-Emodin
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.